Invasive Bladder Carcinoma — Trials

Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

179 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 95
Recruiting: 59
Ph III recruiting: 12
Growth YoY: +28.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 58.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 151–179 of 179 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05097404	Clinical Utility of VI-RADS in Diagnosis of MIBC	unknown	—	73	Samsung Medical CenterOTHER	1	Oct 28, 2021	clinicaltrials
NCT03091764	Evaluation of a Patient-Reported Symptom Index for NMIBC	completed	—	498	University of SydneyOTHER	5	Oct 13, 2021	clinicaltrials
NCT04966130